Article Text

Download PDFPDF
Coincidental detection of T-cell rich B cell lymphoma in the para-aortic lymph nodes of a woman undergoing lymph node dissection for cervical cancer: A case report
  1. H. Abali*,
  2. O. O. Eren,
  3. M. Erman*,
  4. A. H. Uner,
  5. F. Kose§ and
  6. N. Guler*
  1. * Division of Medical Oncology, Hacettepe University Medical School, Ankara, Turkey
  2. Department of Internal Medicine, Hacettepe University Medical School, Ankara, Turkey
  3. Department of Pathology, Hacettepe University Medical School, Ankara, Turkey
  4. § Department of Gynecological Oncology, Social Security Hospital, Ankara, Turkey
  1. Address correspondence and reprint request to: Dr. Hüseyin Abali, Hacettepe University, Institute of Oncology, Sihhiye/Ankara, TURKEY. Email: habali{at}


The diagnosis of cervical squamous cell carcinoma with concurrent T-cell rich B cell lymphoma in dissected lymph nodes has not been reported to our knowledge. In our case, the biopsy of an exophytic lesion at the uterine cervix showed squamous cell carcinoma in a 50-year-old woman presenting with postcoital bleeding. Type III hysterectomy, bilateral salpingo-oophorectemy, bilateral pelvic, para-aortic lymph node dissections were performed. Pathologic examination revealed a T-cell rich B cell lymphoma in some lymph nodes beside squamous cell carcinoma in several of others. ELISA for human immuno-deficiency virus (HIV) was negative. The cervical carcinoma was staged as FIGO clinical stage IB1 and the lymphoma as Ann Arbor IIA. Six cycles of CHOP (cyclophosphamide, adriamycin, vincristine, and prednisolon) chemotherapy for the lymphoma and concomitant pelvic chemoradiotherapy with cisplatin for cervical cancer were given. In this rare coincidence, the best available therapy for each of the diseases should be considered individually. We also suggest that HIV screennig test be carried out, because both diseases may be related to human immuno-deficiency virus, although our patient is HIV-negative.

  • T cell rich
  • B cell lymphoma
  • cervical squamous cell carcinoma
  • therapy

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.